Quantitative Systems Pharmacology (QSP) is a scientific discipline that applies mechanistic, mathematical models and disease platforms to improve the robustness and quality of decision-making across the drug discovery and development process, from discovery research to clinical development. The Pharmacometrics and Systems Pharmacology group at Pfizer, together with the Clinical & Translation Biomarkers team, is seeking a highly motivated postdoctoral fellow to develop, advance, and analyze an end-to-end mechanistic QSP model to better understand therapeutic benefits of incretin therapies beyond weight loss and to generate testable hypotheses for novel mechanisms and indications. The successful candidate will hold a Ph.D. in Applied Mathematics, Engineering, Physics, Pharmaceutical Sciences, Pharmacology, or a closely related discipline, with a strong quantitative mechanistic modeling background and a demonstrated record of scientific publication. Postdoctoral Fellowship Overview The postdoctoral fellow will develop and analyze an end-to-end QSP model that connects incretin pharmacology across tissues to measurable clinical biomarkers and patient-relevant outcomes (e.g., degree of weight loss and nausea tolerability), supporting stronger causal interpretation of trial results and accelerating evaluation of new indications. The postdoctoral fellow will be jointly mentored by scientists with complementary expertise in QSP and clinical/translational biomarkers and will collaborate closely with colleagues across multiple functions within Pfizer including lab scientists, statisticians, computational scientists and subject-matter experts within evidence generation and integrated biology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees